On December 6, 2013, “the leading health and ancestry DNA service” rebranded itself as “the largest DNA ancestry service in the world,” a change it made after the FDA urged it to halt the marketing of its personal genome service until the company provided evidence that its tests actually work.
The FDA had good reason to question 23andMe’s claims: there is still no scientific evidence to support them, and the tests are unlikely to accurately predict disease risk. Surprisingly, 23andMe was not blamed for offering a bogus test – the FDA was blamed for preventing people to access their DNA. All of us – except perhaps those who stand to profit from 23andMe – should be thankful for the FDA’s insistence that the company provide scientific evidence to support its claims.
Read the full, original story: How FDA and 23andMe dance around evidence that is not there
